Abiopharma

Director HALE DAVID F 🟢 acquired 2.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000703

Director WIERENGA WENDELL 🟢 acquired 2.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000699

Bedoya-Toro Munera Maria E 🟢 acquired 9.0K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000704

Director Scott Kathleen D. 🟢 acquired 2.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000697

Director Mento Steven J 🟢 acquired 2.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000695

Van Hoose Kyri K. 🟢 acquired 18.0K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000701

Director FISHER MARY 🟢 acquired 2.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000700

Director Bradrick Brittany 🟢 acquired 2.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000694

Director Zanganeh Mahkam 🟢 acquired 11.2K shares (1 derivative) of Summit Therapeutics Inc. (SMMT) at $17.52 Transaction Date: Jan 02, 2026 | Filing ID: 000003

LO FRANCIS 🟡 adjusted position in 3.1K shares (1 derivative) of Adaptive Biotechnologies Corp (ADPT) at $16.08 Transaction Date: Jan 02, 2026 | Filing ID: 000001

Director DUGGAN ROBERT W 🟢 acquired 11.2K shares (1 derivative) of Summit Therapeutics Inc. (SMMT) at $17.52 Transaction Date: Jan 02, 2026 | Filing ID: 000003

Summit Plc - Statement of changes in beneficial ownership of securities

New Form SCHEDULE 13D/A - Anixa Biosciences Inc Filed: 2026-01-06 AccNo: 0001493152-26-000691 Size: 6 KB

Rosenberg Ellen 🔴 sold 43.1K shares of AMICUS THERAPEUTICS, INC. (FOLD) at $14.27 Transaction Date: Jan 02, 2026 | Filing ID: 005049

Director KOZARICH JOHN W 🔴 sold 467 shares of LIGAND PHARMACEUTICALS INC (LGND) at $192.40 Transaction Date: Jan 02, 2026 | Filing ID: 000004